WaveMan
WaveMan · Company
RVTY · Revvity, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

RVTY Revvity (RVTY) Insider Trading, Ownership & Congress Trades

Medical Devices · Laboratory analytical instruments · CIK 0000031791
Quote by TradingView
Congress · 1Form 144 · 3
Insider buyers, 180 days
0
Funds added, last quarter
300
13F, latest reported quarter

What the filings say about RVTY

Insiders, 180 days
-$1.3M net sold
3 sellers · 75% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 1 sold
Latest: sale, 2026-09-09
Planned sales (Form 144), 90 days
$1.3M
3 notices

Revvity insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, REVVITY, INC. insiders sold a net $1.3M of stock across 53 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Gonzales Anita
VP and CAO
SELL
2026-10-02 SECtraded 2026-10-01
84
$13.1K
+0.9%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 20, 2026.
  • The trade is 1.2% of the 7,117 shares held after it.
  • 2 other insiders sold within 30 days.
  • 300 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP and CAO Gonzales Anita sold about $13.1K of RVTY under a 10b5-1 plan on Oct 1, 2026; 2 other insiders sold within 30 days and 300 funds added in the latest 13F quarter.
Krakowiak Maxwell
Please See Remarks
SELL
2026-09-23 SECtraded 2026-09-21
1,631
$235.7K
+5.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 11.0% of the 14,781 shares held after it.
  • 2 other insiders sold within 30 days.
  • 300 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Please See Remarks Krakowiak Maxwell sold about $235.7K of RVTY under a 10b5-1 plan on Sep 21, 2026; 2 other insiders sold within 30 days and 300 funds added in the latest 13F quarter.
Vohra Tajinder S
Please See Remarks
SELL
2026-09-18 SECtraded 2026-09-16
7,330
$1.0M
+10.6%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Feb 2, 2026.
  • The trade is 110.5% of the 6,635 shares held after it.
  • 2 other insiders sold within 30 days.
  • 300 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Please See Remarks Vohra Tajinder S sold about $1.0M of RVTY under a 10b5-1 plan on Sep 16, 2026; 2 other insiders sold within 30 days and 300 funds added in the latest 13F quarter.
Gonzales Anita
Vice President and CAO
SELL
2026-07-22 SECtraded 2026-07-20
85
$9.3K
+40.3%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Apr 20, 2026.
  • The trade is 1.2% of the 7,201 shares held after it.
  • No other insider sold within 30 days.
  • 300 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Vice President and CAO Gonzales Anita sold about $9.3K of RVTY on Jul 20, 2026; 300 funds added in the latest 13F quarter.
Gonzales Anita
Vice President and CAO
SELL
2026-04-22 SECtraded 2026-04-20
80
$7.4K
+82.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 1.1% of the 7,319 shares held after it.
  • No other insider sold within 30 days.
  • 300 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Vice President and CAO Gonzales Anita sold about $7.4K of RVTY on Apr 20, 2026; 300 funds added in the latest 13F quarter.
53 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 48 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$1.3M over 180 days
-$1.3M over 90 days
below 65% of Medical Devices
Congress
1 member bought in the last year
the lowest in Medical Devices
Funds
300 funds bought in last quarter
more than 88% of Medical Devices
Revenue
+3.7% year over year
below 70% of Medical Devices
Margin
8.4% net margin
more than 79% of Medical Devices
Buybacks
$102.5M repurchased, FY to 2026-07-05
more than 63% of Medical Devices
Short interest
6.2% of the float short (float per yahoo 2026-10-26) · 2.4 days to cover · settled 2026-09-30
more than 67% of Medical Devices
What changed in the last 30 days
Oct 12Rep. Gilbert Cisneros sold $15K to $50K, disclosed 33 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Oct 12Rep. Gilbert Cisneros sold $1.0K to $15K, disclosed 38 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Oct 12Rep. Gilbert Cisneros sold $1.0K to $15K, disclosed 39 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Oct 2VP and CAO Gonzales Anita sold $13.1K under a 10b5-1 plan (Oct 1)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 1Officer Gonzales Anita filed to sell $13.1K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch RVTY

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+66.3%12M
-14%+13%+40%+66%2025-102025-122026-022026-042026-062026-082026-10 2026-02-05 · Singh Prahlad R. sold $1.2M2026-09-16 · Vohra Tajinder S sold $1.0M2026-02-05 · Singh Prahlad R. sold $793.5K2026-02-05 · Goldberg Joel S sold $639.0K2026-02-02 · Vohra Tajinder S sold $601.5K2026-02-05 · Goldberg Joel S sold $356.2K2026-02-05 · Singh Prahlad R. sold $312.4K2026-09-21 · Krakowiak Maxwell sold $235.7K2026-02-05 · Goldberg Joel S sold $224.6K2026-02-24 · Victor Miriame sold $180.9K2026-02-05 · Singh Prahlad R. sold $129.4K2026-02-05 · Singh Prahlad R. sold $109.5K2026-02-23 · McMurry-Heath Michelle sold $58.4K2026-02-05 · Goldberg Joel S sold $54.5K2026-10-01 · Gonzales Anita sold $13.1K2026-07-20 · Gonzales Anita sold $9.3K2026-04-20 · Gonzales Anita sold $7.4K2026-10-01 · Gonzales Anita filed to sell $13.1K2026-09-21 · Krakowiak Maxwell filed to sell $235.7K2026-09-16 · Vohra Tajinder S filed to sell $1.0M2026-07-20 · Gonzales Anita filed to sell $9.3K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns RVTY: institutional holders (13F)

13F holdings, latest reported quarter
Jupiter Topco LLC
8,637,614 sh
$961.0M
EdgePoint Investment Group Inc.
8,544,479 sh
$950.7M
BlackRock, Inc.
7,658,369 sh
$852.1M
VANGUARD CAPITAL MANAGEMENT LLC
7,300,973 sh
$812.3M
VANGUARD PORTFOLIO MANAGEMENT LLC
4,770,448 sh
$530.8M

Congress trades in RVTY

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Gilbert Cisneros
Sold 2026-09-09 · disclosed 33 days later
$15,001 - $50,000
Gilbert Cisneros
Sold 2026-09-04 · disclosed 38 days later
$1,001 - $15,000
Gilbert Cisneros
Sold 2026-09-03 · disclosed 39 days later
$1,001 - $15,000
Gilbert Cisneros
Bought 2026-05-04 · disclosed 35 days later
$15,001 - $50,000
Gilbert Cisneros
Bought 2026-05-01 · disclosed 7 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

RVTY planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Gonzales Anita
Filed 2026-10-01
$13.1K
Krakowiak Maxwell
Filed 2026-09-21
$235.7K
Vohra Tajinder S
Filed 2026-09-16
$1.0M
Gonzales Anita
Filed 2026-07-20
$9.3K

RVTY mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Paradigm Select Fund
$10.5M position · as of 2026-06-30
3.7%
MONONGAHELA ALL CAP VALUE FUND
$1.7M position · as of 2026-07-31
3.5%
Janus Henderson Enterprise Fund
$639.7M position · as of 2026-06-30
2.9%
Guardian Mid Cap Traditional Growth VIP Fund
$1.1M position · as of 2026-06-30
2.9%
EQ/Janus Enterprise Portfolio
$43.2M position · as of 2026-06-30
2.8%
Transamerica Janus Mid-Cap Growth VP
$26.9M position · as of 2026-06-30
2.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Revvity Inc. Pac (Revvity Pac)
Cycle 2026 · $16K spent
$31.9K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Prahlad R. Singh
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$13.8M
$5.8M
$3.9M
-32%
+5%
2024
$11.9M
$11.5M
$2.9M
-21%
+0%
2023
$9.1M
$3.6M
$2.2M
-23%
+4%
2022
$10.6M
$1.8M
$2.1M
-2%
+7%
2021
$9.7M
$22.4M
$2.4M
+40%
+39%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.3M sold by insiders over 180 days, 300 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $1.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

RVTY financials

Revenue growth
+3.7%
XBRL, annual
Net margin
8.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.9B
four quarters, 2025-06-30 to 2026-07-05
Net margin, TTM
+8.2%
net income over revenue, 2025-06-30 to 2026-07-05
Free cash flow, TTM
$558.1M
operating cash flow minus capex, 2025-06-30 to 2026-07-05
Debt to equity
0.44x
long-term 2026-07-05 plus current 2026-07-05; equity 2026-07-05
Cash flow to debt
0.20x
TTM operating cash flow over long-term 2026-07-05 plus current 2026-07-05
Return on equity
+3.2%
TTM net income over average of 2025-06-29 and 2026-07-05
Return on assets
+1.9%
TTM net income over average of 2025-06-29 and 2026-07-05
Return on invested capital
+3.4%
operating income after a 9.0% effective tax rate, over long-term 2026-07-05 plus current 2026-07-05 plus average of 2025-06-29 and 2026-07-05 minus cash
Return on capital employed
+3.2%
operating income (EBIT proxy) over average of 2025-06-29 and 2026-07-05 minus current liabilities
P/E, trailing
75.97x
close 2026-10-23 over four quarters of diluted EPS, 2025-06-30 to 2026-07-05
Enterprise value
$19.9B
market value at close 2026-10-23 on 2026-08-06 shares, plus long-term 2026-07-05 plus current 2026-07-05, minus cash 2026-07-05
FCF yield
+3.2%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing EPS growth -11%, PEG needs growth
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122023-01
Revenue$2.9B$2.8B$2.8B$3.3B
Gross profitn/an/an/a$2.0B
Operating income$356.6M$346.7M$300.6M$742.7M
Net income$241.2M$270.4M$693.1M$569.2M
EPS (diluted)2.072.205.554.50
Operating cash flow$582.9M$628.3M$91.3M$679.8M
Cash$919.9M$1.2B$913.2M$454.4M
Long-term debt$2.6B$3.2B$3.2B$3.9B
Buybacks$820.8M$369.6M$388.9M$80.6M
Dividends paid$32.8M$34.5M$35.0M$35.3M
SEC XBRL, fiscal years, as known on 2026-10-27

RVTY Stock Sonar score 6/7 axes

Find similar shapesCompare

RVTY ranks highest on risk and compliance (63rd percentile) and profitability (58th), and lowest on insider conviction (30th), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
58
Inputs
  • Return on equity+3.2% · 72 pct, sector of 183
  • Return on assets+1.9% · 74 pct, sector of 214
  • Return on invested capital+3.4% · 11 pct, sector of 36
  • Return on capital employed+3.2% · 73 pct, sector of 188
Financial health
54
Inputs
  • Debt to equity0.44x · 40 pct, sector of 159
  • Cash flow to debt0.20x · 68 pct, sector of 150
Growth
30
Inputs
  • Revenue growth, YoY+3.7% · 30 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
30
Inputs
  • Net Form 4 buying (codes P and S), 180d-$9K · 60 pct, sector of 140
  • Insider buyers, 180d0 · 0 pct, sector of 142
Institutional and government
54
Inputs
  • Funds adding, latest quarter300 · 88 pct, sector of 191
  • Congress net buyers, 365d0 · 40 pct, universe of 719
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$135K · 33 pct, sector of 50
Risk and compliance
63
Inputs
  • Short interest, % of float+6.2% · 42 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+10.9% · 48 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

RVTY filings, in plain words

Are Revvity insiders buying or selling RVTY?

In the 180 days to 2026-10-27, Revvity insiders were net sellers, a net $1.3M across purchases and sales reported on Form 4, by 3 sellers.

Have members of Congress traded RVTY?

Yes. In the year to 2026-10-27, 1 House member disclosed buying RVTY and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-09-09.

Are there planned insider sales of RVTY?

Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.3M of stock; the latest, by Gonzales Anita, was filed 2026-10-01.

Read the full summary

In the 180 days to 2026-10-27, Revvity insiders were net sellers of RVTY, a net $1.3M across purchases and sales reported on Form 4 by 3 sellers. 75% of the 4 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 1 member of Congress disclosed buying RVTY and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-09-09. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies